全文获取类型
收费全文 | 673篇 |
免费 | 33篇 |
国内免费 | 19篇 |
专业分类
儿科学 | 22篇 |
妇产科学 | 12篇 |
基础医学 | 50篇 |
口腔科学 | 70篇 |
临床医学 | 66篇 |
内科学 | 147篇 |
皮肤病学 | 12篇 |
神经病学 | 17篇 |
特种医学 | 116篇 |
外科学 | 58篇 |
综合类 | 14篇 |
预防医学 | 83篇 |
眼科学 | 1篇 |
药学 | 34篇 |
中国医学 | 9篇 |
肿瘤学 | 14篇 |
出版年
2023年 | 7篇 |
2021年 | 8篇 |
2018年 | 5篇 |
2017年 | 4篇 |
2016年 | 8篇 |
2015年 | 5篇 |
2014年 | 18篇 |
2013年 | 20篇 |
2012年 | 21篇 |
2011年 | 19篇 |
2010年 | 24篇 |
2009年 | 21篇 |
2008年 | 11篇 |
2007年 | 18篇 |
2006年 | 14篇 |
2005年 | 25篇 |
2004年 | 15篇 |
2003年 | 19篇 |
2002年 | 15篇 |
2001年 | 13篇 |
2000年 | 14篇 |
1999年 | 11篇 |
1998年 | 31篇 |
1997年 | 21篇 |
1996年 | 12篇 |
1995年 | 21篇 |
1994年 | 13篇 |
1993年 | 17篇 |
1992年 | 10篇 |
1991年 | 7篇 |
1990年 | 12篇 |
1989年 | 28篇 |
1988年 | 24篇 |
1987年 | 27篇 |
1986年 | 23篇 |
1985年 | 19篇 |
1984年 | 8篇 |
1983年 | 5篇 |
1982年 | 10篇 |
1981年 | 10篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1978年 | 7篇 |
1977年 | 11篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1971年 | 6篇 |
1970年 | 5篇 |
1969年 | 5篇 |
1931年 | 4篇 |
排序方式: 共有725条查询结果,搜索用时 15 毫秒
81.
Heterogeneity in human neutrophil, macrophage and eosinophil progenitor cells demonstrated by velocity sedimentation separation 总被引:2,自引:0,他引:2
Progenitor cells of neutrophils, monocyte-macrophages, and eosinophils in human marrow were enumerated in agar cultures stimulated by placental conditioned medium or white cell underlayers. Fractionation of marrow populations by velocity sedimentation showed that the profiles of neutrophil and macrophage colony-forming cells shifted from a peak of 8-9 mm/hr in 7-day cultures to a peak of 6-7 mm/hr in 14-day cultures. This shift was due to degeneration of some early colonies formed by rapidly sedimenting cells and the delayed formation of colonies by slowly sedimenting cells. Eosinophil colony formation was delayed until the second week of incubation. Further evidence of heterogeneity was the observation that rapidly sedimenting colony forming cells were more responsive to stimulation than more slowly sedimenting cells. In the macrophage and eosinophil populations, cluster-forming cells were partially segregatable form colony-forming cells. The observed heterogeneity was similar to the described previously in the mouse and suggests that separate subpopulations of progenitor cells may exist within each hemopoietic family that could possibly give rise to functionally different progeny. 相似文献
82.
Murine hematopoietic stem and progenitor cells: I. Enrichment and biologic characterization 总被引:2,自引:5,他引:2
Murine bone marrow cells were fractionated by fluorescence-activated cell sorting into Rh123lo Lin- c-kit+ Ly6A+, Rh123hi Lin-c-kit+ Ly6A+, and Lin- c-kit+ Ly6A- populations within which most, if not all, of the hematopoietic activities of the marrow resided. The Rh123lo Lin- c- kit+Ly6A+ cells, which consist exclusively of small- or medium-sized lymphocyte-like cells, are highly enriched for long-term hematopoietic in vivo repopulating cells. The enrichment factor for these cells from the marrow was estimated as 2,000-fold. The Rh123hi Lin- c-kit+ Ly6A+ cells, although also highly enriched for day-12 spleen colony-forming units, were relatively depleted of long-term in vivo repopulation capacity. Most, if not all Lin- c-kit+ Ly6A- cells were Rb123hi. In contrast to both Rh123lo and Rh123hi Lin- c-kit+ Ly6A+ stem cell populations, the Lin- c-kit+ Ly6A- cells can be stimulated to proliferate in vitro in the presence of single cytokines, which is a characteristic of committed progenitor cells. No marked synergistic interactions between individual cytokines were observed with this cell population. Both Rh123hi Lin- c-kit+ Ly6A+ mature stem cell and Lin- c- kit+ Ly6A- progenitor cell populations displayed in vivo repopulation kinetics resembling those of the putative short-term hematopoietic repopulating cells. 相似文献
83.
84.
P-selectin is an adhesion receptor for leukocytes expressed byactivated platelets and endothelial cells. To assess a possible role ofP-selectin in platelet clearance, we adapted an in vivo biotinylationtechnique in mice. Wild-type and P-selectin-deficient mice wereinfused with N-hydroxysuccinimido biotin. The survival of biotinylatedplatelets was followed by flow cytometry after labeling withfluorescent streptavidin. Both wild-type and P-selectin-deficient platelets presented identical life spans of about 4.7 days, suggesting that P-selectin does not play a role in platelet turnover. When biotinylated platelets were isolated, activated with thrombin, andreinjected into mice, the rate of platelet clearance was unchanged. Incontrast, storage of platelets at 4°C caused a significant reduction in their life span in vivo but again no significant differences were observed between the two genotypes. The infused thrombin-activated platelets rapidly lost their surface P-selectin incirculation, and this loss was accompanied by the simultaneous appearance of a 100-kD P-selectin fragment in the plasma. This observation suggests that the platelet membrane P-selectin was shed bycleavage. In conclusion, this study shows that P-selectin, despite itsbinding to leukocytes, does not mediate platelet clearance. However,the generation of a soluble form of P-selectin on platelet activationmay have biological implications in modulating leukocyte recruitment orthrombus growth. 相似文献
85.
J E Muller R E Rude E Braunwald T D Hartwell R Roberts B E Sobel C Ritter C B Parker A S Jaffe P H Stone 《Annals of internal medicine》1988,108(1):1-6
The occurrence, outcome, and predictors of myocardial infarct extension were determined in 848 patients with acute myocardial infarction. An increase in the level of plasma MB creatine kinase activity was used to detect extension, which occurred in 71 of 848 patients (8.4%). For these patients, hospital mortality was more than four times higher than for those without extension (30% versus 7%, P less than 0.01). However, for patients surviving the initial hospitalization, there was no significant difference in mortality during the following year (12% compared with 9%). Multivariable analyses indicated that extension was more likely to occur in patients with recurrent ischemic pain during the second hospital day, a history of previous myocardial infarction, and ST segment depression on the admission electrocardiogram. The occurrence of extension in patients with two of these risk factors was more than twice that of patients without any of the risk factors (15.1% compared with 5.8%). Patients with these risk factors should be considered for early coronary angiography and possible intervention to prevent infarct extension and its sequellae. 相似文献
86.
A microculture assay for murine granulocyte-macrophage colony- stimulating factor (GM-CSF) has been developed using fetal liver GM colony-forming cells (CFC) isolated by fluorescence-activated cell sorting. These GM-CFC are free of mature hemopoietic cells, such as granulocytes and macrophages, which may interfere with direct assays for GM-CSF. The assay procedure allows the quantitation of GM-CSF within 48 hr by measuring the number of cells produced from 50 GM-CFC in microcultures (15 microliter). The assay is particularly simple to set up and score and yet, because of the reduced volumes, this assay is still capable of detecting 0.2 pg (i.e., 0.2 U) of GM-CSF within 48 hr, i.e., 100 times less GM-CSF than the conventional soft agar assay. By allowing the microcultures to develop for 7 days, the extra proliferation allows a further tenfold increase in the sensitivity of CSF detection. The time and cost of setting up hundreds of GM-CSF assays for fractions from chromatographic columns, e.g., reverse phase high performance liquid chromatography, is reduced by at least five- fold. Enough GM-CFC can be isolated and stored frozen in one afternoon to provide sufficient cells for the daily assay of 200 samples of GM- CSF for several months. Microassay results for several sources of GM- CSF at different stages of purification are compared to the results obtained from the soft agar assay. 相似文献
87.
Ng VL; Hwang KM; Reyes GR; Kaplan LD; Khayam-Bashi H; Hadley WK; McGrath MS 《Blood》1988,71(5):1397-1401
We observed a human immunodeficiency virus (HIV)-infected homosexual male with AIDS related complex (ARC) who had a serum globulin level of 80 g/L. Serum protein electrophoresis revealed a gamma globulin fraction of 40 g/L, of which 50% (20 g/L) was contained within a paraprotein spike, comprised predominantly of IgG kappa. This patient also had high titer anti-HIV antibodies in his serum, which were Western blot reactive at a final dilution of 1:500,000, and recognized gp120env, p66pol, p55gag, p53pol, p41gag, and p24gag. Because paraproteins in the past have been shown to be directed against specific antigens, we purified this patient's paraprotein using a modified high performance liquid chromatography (HPLC)-hydroxylapatite procedure and tested the purified paraprotein for anti-HIV antibody activity. The purified paraprotein retained anti-HIV antibody activity to a final dilution of 1:100,000, and recognized p66pol, p55gag, p53pol, p41gag, and p24gag. The recognition of both "gag" and "pol" gene products suggested that the purified paraprotein might not be monoclonal in origin. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) demonstrated that the purified paraprotein contained at least two immunoglobulin light chain species (Mol wt 30 to 33 Kd). Affinity chromatography of the purified paraprotein using a p24- Sepharose 4B matrix separated the "gag" and "pol" antibody activities. Immunoglobulin gene rearrangement analysis of a bone marrow aspirate (which contained 15% plasma cells) failed to reveal a clonal population of immunoglobulin producing cells. We conclude that this patient's paraprotein accounted for most of the anti-HIV activity present in whole serum, and that this paraprotein was not monoclonal in origin. 相似文献
88.
Marcus J?r?s Peter G. Miller Lisa P. Chu Rishi V. Puram Emma C. Fink Rebekka K. Schneider Fatima Al-Shahrour Pablo Pe?a L. Jordan Breyfogle Kimberly A. Hartwell Marie E. McConkey Glenn S. Cowley David E. Root Michael G. Kharas Ann Mullally Benjamin L. Ebert 《The Journal of experimental medicine》2014,211(4):605-612
Despite extensive insights into the underlying genetics and biology of acute myeloid leukemia (AML), overall survival remains poor and new therapies are needed. We found that casein kinase 1 α (Csnk1a1), a serine-threonine kinase, is essential for AML cell survival in vivo. Normal hematopoietic stem and progenitor cells (HSPCs) were relatively less affected by shRNA-mediated knockdown of Csnk1a1. To identify downstream mediators of Csnk1a1 critical for leukemia cells, we performed an in vivo pooled shRNA screen and gene expression profiling. We found that Csnk1a1 knockdown results in decreased Rps6 phosphorylation, increased p53 activity, and myeloid differentiation. Consistent with these observations, p53-null leukemias were insensitive to Csnk1a1 knockdown. We further evaluated whether D4476, a casein kinase 1 inhibitor, would exhibit selective antileukemic effects. Treatment of leukemia stem cells (LSCs) with D4476 showed highly selective killing of LSCs over normal HSPCs. In summary, these findings demonstrate that Csnk1a1 inhibition causes reduced Rps6 phosphorylation and activation of p53, resulting in selective elimination of leukemia cells, revealing Csnk1a1 as a potential therapeutic target for the treatment of AML.Although tremendous progress has been made in identifying recurrent somatic mutations that drive acute myeloid leukemia (AML) pathogenesis, many of these genetic lesions cause a loss of protein function and do not suggest clear therapeutic opportunities (Welch et al., 2012). Genetic screens have emerged as powerful approaches to identify vulnerabilities and therapeutic opportunities in cancer cells (Luo et al., 2009; Zuber et al., 2011). In a recent in vivo shRNA screen (Miller et al., 2013) using primary mouse MLL-AF9 leukemia cells (Krivtsov et al., 2006; Somervaille and Cleary, 2006), we found that cells expressing Csnk1a1 shRNAs were powerfully depleted over time, indicating that Csnk1a1 is required for the survival of MLL-AF9 leukemia-propagating cells and may represent a novel therapeutic target for AML.Csnk1a1, a serine-threonine kinase, is a central regulator of multiple pathways that are critical for normal and malignant stem cell biology, including the β catenin and p53 pathways (Liu et al., 2002; Wang et al., 2010; Zhao et al., 2010; Elyada et al., 2011; Luis et al., 2011). More precisely, Csnk1a1 suppression increases β catenin and p53 activity (Liu et al., 2002; Chen et al., 2005; Huart et al., 2009). Csnk1a1 plays a critical role in the biology of diffuse large B cell lymphoma by regulating NF-κB signaling (Bidère et al., 2009), but the role of Csnk1a1 in leukemia has not been examined. We therefore sought to explore the role of Csnk1a1 in AML. 相似文献
89.
90.
The clearance of vancomycin is significantly reduced in patients with acute, as well as, chronic renal failure. Although multiple-dosage regimen adjustment techniques have been proposed for these patients, there is little quantitative data to guide the individualization of vancomycin therapy in acute renal failure patients who are receiving continuous renal replacement therapy (CRRT). To determine appropriate vancomycin dosing strategies for patients receiving continuous venovenous hemofiltration (CVVH) and continuous venovenous hemodialysis (CVVHD), we performed controlled clearance studies in five stable hemodialysis patients with three hemofilters: an acrylonitrile copolymer 0.6 m2 (AN69), polymethylmethacrylate 2.1 m2 (PMMA), and polysulfone 0.65 m2 (PS). Patients received 500 mg of vancomycin intravenously at least 12 hours before the start of the clearance study. The concentration of vancomycin in multiple plasma and dialysate/ultrafiltrate samples was determined by EMIT (Syva, Palo Alto, CA). The diffusional clearance and sieving coefficient (SC) of vancomycin were compared by a mixed-model repeated-measures analysis of variance (ANOVA) with filter and blood (Q(B)), dialysate inflow (Q(DI)), or ultrafiltration rate (Q(UF)) as the main effects and patient as a random effect. Vancomycin was moderately protein bound in these patients; free fraction ranged from 49% to 83%. The SCs of the three filters were similar and significantly correlated with the free fraction of vancomycin (P = 0.01; r2 = 0.465). Significant linear relationships were observed between the diffusional clearance of vancomycin and Q(DI) for all three filters: AN69 (slope = 0.482; r2 = 0.880); PMMA (slope = 0.853; r2 = 0.966); and PS (slope = 0.658; r2 = 0.887). The slope of this relationship for the PMMA filter was significantly greater than that of the AN69 and PS filters. The clearance of vancomycin, urea, and creatinine, however, was essentially constant at all Q(B)s for all three filters. Thus, the clearance of vancomycin was not membrane dependent during CVVH. However, during CVVHD, membrane dependence of vancomycin clearance was noted at a Q(DI) greater than 16.7 mL/min; vancomycin clearance with PMMA at a Q(DI) of 25 mL/min was 66% and 43% greater than that with the AN69 and PS filters, respectively. CVVH (62% to 262%) and CVVHD (90% to 540%) can significantly augment the clearance of vancomycin in acute renal failure patients. Dosing strategies for individualization of vancomycin therapy in patients receiving CVVH and CVVHD are proposed. 相似文献